Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors
The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.
The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.
ed more frequently for surgical resection of NF-PNETs. The evidence for using MIS for NF-PNETs is still being determined and controversial. Materials and Methods: PubMed,…
Large batteries are needed for cities and metro areas to run off solar or wind power. Researchers in ACS Central Science have developed a cost-effective…
A wise man once said: ‘Humans are the only species smart enough to engineer their own food – and dumb enough to eat it.’ For…
Y Combinator-backed startup Origami Agents has raised $2 million in seed funding to build AI research agents that augment, rather than replace, human sales teams,…
RNA-based therapeutics like inclisiran and vutrisiran could redefine treatment paradigms for cardiovascular diseases and related comorbidities.
If you hadn’t heard, there’s a new AI star in town: DeepSeek, the subsidiary of Hong Kong-based quantitative analysis (quant) firm High-Flyer Capital Management, has…
Our climate change resources have been designed to introduce the topic of the affects climate change is having on our world
New fees for claims appeals, paperwork rules for testing and time limits for certain services are novel ways to constrain spending that have providers fuming.
Trump and Newsom have been trading barbs over water. How far could this dispute go?